JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 12,960
+120 (0.93%)
Apr 24, 2026, 3:30 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 200.68 billion as of April 24, 2026. Its market cap has increased by 15.71% in one year.
Market Cap
200.68B
Enterprise Value
240.76B
Revenue
257.83B
Ranking
n/a
PE Ratio
7.02
Stock Price
12,960.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 200.68B, a decrease of -40.98%. That is a compound annual growth rate of -5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 198.82B | -0.08% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daewon Pharmaceutical | 229.77B |
| Samjin Pharmaceuticals | 229.10B |
| Suheung | 219.16B |
| Ilyang Pharmaceutical Co.,Ltd | 207.57B |
| Samil Pharmaceutical Co.,Ltd | 204.23B |
| REYON Pharmaceutical | 202.85B |
| AptaBio Therapeutics | 202.55B |
| Jeil Pharmaceutical Co.,Ltd | 201.82B |